Bigbear Pharmaceutical·Medication Guide

• The FDA has expanded the indications for lorlatinib, approving it for first-line treatment of ALK-po

  On March 3, 2021, the U.S. Food and Drug Administration (FDA) approved Pfizer's supplemental New Drug Application (sNDA) for lorlatinib, expanding···【Read More】

  Update: 2026-03-05Source: Haiou HealthViews: 72

• Detailed product information for Lorlatinib: indications, dosage, side effects, and precautions

  Lorlatinib, the world's first third-generation ALK (anaplastic lymphoma kinase)/ROS1 tyrosine kinase inhibitor (TKI), was developed by Pfizer for ···【Read More】

  Update: 2026-03-05Source: Haiou HealthViews: 72

• Lorlatinib Explained: Uses, Mechanism of Action, and Clinical Outcomes

  Lorlatinib was approved for marketing in China by the National Medical Products Administration (NMPA) in April 2022 and has been included in the Natio···【Read More】

  Update: 2026-03-05Source: Haiou HealthViews: 73

• Managing Lorlatinib Side Effects: A Guide to Common Symptoms and How to Cope

  Lorlatinib is a novel third-generation small-molecule ALK/ROS1 dual-target inhibitor developed by Pfizer Inc.Side effects requiring immediate medical ···【Read More】

  Update: 2026-03-05Source: Haiou HealthViews: 72

• Lorlatinib Dosage Guide: What is the Recommended Starting Dose for ALK-Positive Lung Cancer?

  Lorlatinib was first approved for marketing in Japan in September 2018, followed by approval from the U.S. Food and Drug Administration (FDA) in Novem···【Read More】

  Update: 2026-03-05Source: Haiou HealthViews: 73

• FDA approves cannefenib in combination with bimetinib

  On October 12, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) has approved cannefenib in combination with bimetinib for the t···【Read More】

  Update: 2026-03-05Source: Haiou HealthViews: 71

• Binimetinib (Mektovi) Uses, Dosage, Side Effects & Patient Tips

  In June 2018, the U.S. Food and Drug Administration (FDA) approved binimetinib for marketing as a treatment for unresectable metastatic melanoma or me···【Read More】

  Update: 2026-03-05Source: Haiou HealthViews: 73

• What is lusutrombopag

  Lusutrombopag is a man-made form of a protein that increases production of platelets (blood-clotting cells) in your body. Lusutrombopag can lower the ···【Read More】

  Update: 2026-03-05Source: Haiou HealthViews: 73

• What happens if I miss a dose of Lusutrombopag

  Take the missed dose on the same day you remember it. Take your next dose at the regular time and stay on your once-daily schedule. Do not use 2 doses···【Read More】

  Update: 2026-03-05Source: Haiou HealthViews: 74

• What should I avoid while taking lusutrombopag

  Follow your doctor's instructions about any restrictions on food, beverages, or activity.【Read More】

  Update: 2026-03-05Source: Haiou HealthViews: 73

• What other drugs will affect lusutrombopag

  Other drugs may affect lusutrombopag, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all···【Read More】

  Update: 2026-03-05Source: Haiou HealthViews: 72

• Latest Prices of Different Versions of Lusutrombopag

  Latest Prices of Different Versions of LusutrombopagLusutrombopag is a novel oral small‑molecule thrombopoietin receptor agonist (TPO‑RA). It promotes···【Read More】

  Update: 2026-03-05Source: Haiou HealthViews: 72

• Latest Price of Lusutrombopag in 2026

  Latest Price of Lusutrombopag in 2026Lusutrombopag is an oral small‑molecule thrombopoietin‑mimetic drug indicated for the treatment of thrombocytopen···【Read More】

  Update: 2026-03-05Source: Haiou HealthViews: 70

• Dosage, Administration and Precautions for Lusutrombopag

  Dosage and AdministrationDosing RegimenThe starting dose is 3 mg once daily, administered on an empty stomach (1 hour before or 2 hours after a meal).···【Read More】

  Update: 2026-03-05Source: Haiou HealthViews: 71

• What Is Lusutrombopag Used For

  Lusutrombopag is an oral thrombopoietin receptor agonist (TPO-RA). It is mainly used to treat increased bleeding risk due to thrombocytopenia in adult···【Read More】

  Update: 2026-03-05Source: Haiou HealthViews: 71